Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Chief Scientific Officer | McNamara Peter | Aug 25, 2026 | Sell | $1.57K | 43 |
| Chief Scientific Officer | McNamara Peter | Aug 12, 2026 | Sell | $1.51K | 43 |
| Chief Scientific Officer | McNamara Peter | Jun 30, 2026 | Sell | $6.02K | 172 |
| Chief Medical Officer | Ruddy Marcella K. | May 4, 2026 | Sell | $31.95K | 1,065 |
| Chief Medical Officer | Ruddy Marcella K. | Apr 1, 2026 | Sell | $31.05K | 1,000 |
| Chief Medical Officer | Ruddy Marcella K. | Mar 6, 2026 | Sell | $300K | 10,000 |
| Chief Scientific Officer | McNamara Peter | Mar 6, 2026 | Sell | $181.41K | 6,047 |
| Chief Scientific Officer | McNamara Peter | Mar 6, 2026 | Sell | $7.53K | 215 |
| Chief Scientific Officer | McNamara Peter | Mar 4, 2026 | Sell | $41.25K | 1,650 |
| Chief Scientific Officer | McNamara Peter | Mar 3, 2026 | Sell | $36.38K | 1,649 |
| CEO | REICIN ALISE | Feb 11, 2026 | Buy | $52.75K | 2,500 |
| CFO | Lochner Daniel | Feb 10, 2026 | Buy | $129.66K | 6,000 |
| Director | SPRINGER TIMOTHY A | Apr 11, 2025 | Buy | $154.59K | 9,478 |
| Director | SPRINGER TIMOTHY A | Apr 11, 2025 | Buy | $875.94K | 53,706 |
| Director | SPRINGER TIMOTHY A | Apr 10, 2025 | Buy | $135.38K | 8,092 |
| Director | SPRINGER TIMOTHY A | Apr 10, 2025 | Buy | $767.2K | 45,858 |
| Director | SPRINGER TIMOTHY A | Apr 9, 2025 | Buy | $41.83K | 2,861 |
| Director | SPRINGER TIMOTHY A | Apr 9, 2025 | Buy | $13.05K | 857 |
| Director | SPRINGER TIMOTHY A | Apr 9, 2025 | Buy | $237.06K | 16,215 |
| Director | SPRINGER TIMOTHY A | Apr 9, 2025 | Buy | $73.96K | 4,856 |
| Director | SPRINGER TIMOTHY A | Apr 7, 2025 | Buy | $1.5M | 87,500 |
| Director | MCGUIRE TERRANCE | Apr 7, 2025 | Sell | $8.55M | 500,000 |
| Director | SPRINGER TIMOTHY A | Apr 7, 2025 | Buy | $7.05M | 412,500 |
| CFO | Lochner Daniel | Feb 5, 2025 | Buy | $249.96K | 4,617 |
| Director | SPRINGER TIMOTHY A | Feb 5, 2025 | Buy | $7M | 129,294 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
